Compare RZLT & FNLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RZLT | FNLC |
|---|---|---|
| Founded | 2010 | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.3M | 288.7M |
| IPO Year | N/A | 1999 |
| Metric | RZLT | FNLC |
|---|---|---|
| Price | $2.67 | $26.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $12.33 | N/A |
| AVG Volume (30 Days) | ★ 14.6M | 20.3K |
| Earning Date | 02-11-2026 | 01-21-2026 |
| Dividend Yield | N/A | ★ 5.51% |
| EPS Growth | N/A | ★ 18.07 |
| EPS | N/A | ★ 2.81 |
| Revenue | N/A | ★ $88,119,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.55 |
| Revenue Growth | N/A | ★ 12.70 |
| 52 Week Low | $1.07 | $22.11 |
| 52 Week High | $11.46 | $28.60 |
| Indicator | RZLT | FNLC |
|---|---|---|
| Relative Strength Index (RSI) | 31.54 | 51.35 |
| Support Level | $1.78 | $28.05 |
| Resistance Level | $2.82 | $28.60 |
| Average True Range (ATR) | 0.49 | 0.51 |
| MACD | -0.20 | -0.10 |
| Stochastic Oscillator | 15.55 | 34.21 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.